Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

By S. Kim, R. Cristescu, A. Bass, Kyoung-Mee Kim, J. Odegaard, Kyung-Mi Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mijin Lee and 13 more. Nature Medicine, 2018

1,426 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/8a1fad1e375df5dc187c47a638696c646ee2f5a8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Zeng
2. R. Zhou
3. J. Bin
4. Y. Liao
5. Min Shi
6. W. Liao
7. Ruifeng Xu
8. Jingwen Zhang

Citations in the corpus

• Analyzing the Level of Accessibility of Public Urban Green Spaces to Different Socially Vulnerable Groups of People (2018, neutral): “[86] conducted a study in Seoul City on the accessibility to health care centers (hospitals).”
• Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures (2019, methodology): “Several studies have indicated that EBVþ gastric cancer does not exhibit higher TMB or MSI, but can respond to immune-checkpoint therapy (15, 63), suggesting that the TMEscore may be more useful for predicting clinical benefits in patients with gastric cancer treated with immunotherapy than TMB or M”
• Gastric cancer treatment: recent progress and future perspectives (2023, result): “While a Korean study with a small sample size (n = 6) once reported a 100% response rate in EBV-positive advanced GC [80], several other studies did not demonstrate a high response rate [81–83].”